The Week in Review: Pfizer Builds China Relationships

Pfizer will underwrite basic research at Shanghai Institutes for Biological Sciences: the big pharma and Shanghai's Fudan University will also create a work-study graduate program in Clinical Data Management and Statistical Programming; aTyr Pharma raised $12 million in new capital; Neusoft Medical Systems began shipping its NeuViz 16 multi-slice CT scanner to the US; Lotus Pharma received a patent pending notice for a controlled release form of a diabetes drug; SciClone Pharma in-licensed China rights to an anti-nausea drug; the State Council of China detailed its 2009 plans for healthcare reform; and China Medical Technologies (中国医疗技术公司) watched its share price drop after the company lowered guidance. More details... Stock Symbols: (NYSE: PFE) (OTCBB: LTUS) (NSDQ: SCLN) (NSDQ:CMED)